ArticleJournal of cellular and molecular medicine2026
Circular RNA circ_0003423 Promotes Osteoarthritis Progression by Sponging miR-330-5p to Upregulate TWIST1-Mediated Chondrocyte Inflammation and Extracellular Matrix Degradation.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Osteoarthritis (OA) is a debilitating degenerative joint disease characterized by progressive articular cartilage destruction, persistent inflammation, and functional impairment. Circular RNAs (CireRNAs) have emerged as critical epigenetic regulators in OA pathogenesis; however, the precise functional role of Circ_0003423 in OA remains largely unexplored. This study aimed to elucidate the expression pattern, biological functions, and underlying molecular mechanism of Circ_0003423 in OA progression. Bioinformatic analysis of the GSE178724 dataset was performed to identify differentially expressed CircRNAs in OA cartilage. Circ_0003423 and miR-330-5p expression levels were quantified by QRT-PCR in IL-1β-stimulated chondrocytes. The interaction between Circ_0003423 and miR-330-5p, and between miR-330-5p and TWIST1, was validated by RNA pull-down and dual-luciferase reporter assays. Western blotting was employed to assess TWIST1, Collagen I, Collagen II, ADAMTS5, MMP3, MMP13, total NF-κB p65, and phosphorylated NF-κB p65 (p-NF-κB p65) expression. Chondrocyte proliferation and apoptosis were evaluated by CCK-8 and EdU assays and flow cytometry, respectively. Pro-inflammatory cytokine levels were measured by ELISA. An OA mouse model was established via destabilization of the medial meniscus (DMM), and Circ_0003423 was silenced by intra-articular injection of lentiviral shRNA to validate In vivo findings. Circ_0003423 was significantly upregulated in OA cartilage and IL-1β-stimulated chondrocytes. Silencing Circ_0003423 rescued IL-1β-induced proliferation inhibition, reduced apoptosis, attenuated pro-inflammatory cytokine secretion, and mitigated ECM degradation. Mechanistically, Circ_0003423 functioned as a ceRNA by directly sponging miR-330-5p, which targeted TWIST1 to activate downstream NF-κB signalling and upregulate ADAMTS5, MMP3, and MMP13, with concomitant collagen downregulation. Rescue experiments confirmed that miR-330-5p inhibition or TWIST1 overexpression abrogated the protective effects of circ_0003423 silencing. In vivo, circ_0003423 silencing upregulated miR-330-5p, suppressed TWIST1/NF-κB/MMP3/MMP13 activation, and alleviated cartilage degeneration, chondrocyte apoptosis, and inflammatory responses in DMM mice. Circ_0003423 drives OA progression by functioning as a ceRNA to sponge miR-330-5p, thereby de-repressing TWIST1 and activating downstream NF-κB signalling and MMP3/MMP13-mediated ECM destruction. Targeting circ_0003423 represents a promising therapeutic strategy for OA intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.